ArticleInternational journal of molecular sciences2023

A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC.

Maria Pia Adorni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.